𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk factors for damage in childhood-onset systemic lupus erythematosus: Cumulative disease activity and medication use predict disease damage

✍ Scribed by Hermine I. Brunner; Earl D. Silverman; Theresa To; Claire Bombardier; Brian M. Feldman

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
79 KB
Volume
46
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health-related quality of life in juveni
Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage
✍ Ruperto, Nicolino ;Buratti, Silvia ;Duarte-Salazar, Carolina ;Pistorio, Angela ; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

## Abstract ## Objective To assess the health‐related quality of life (HRQL) of patients with juvenile‐onset systemic lupus erythematosus (JSLE) and its relationship with disease activity and accumulated damage. ## Methods In this cross‐sectional study, HRQL was assessed using the Child Health Q

Platelet-activating factor–acetylhydrola
Platelet-activating factor–acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus
✍ Anna Cederholm; Elisabet Svenungsson; Dominique Stengel; Guo-Zhong Fei; A. Graha 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract ## Objective There is an important inflammatory component to atherosclerosis and cardiovascular disease (CVD). It is therefore interesting that the risk of CVD is high in inflammatory diseases such as systemic lupus erythematosus (SLE). In this study, we investigated nontraditional ris

Systemic lupus erythematosus in a multie
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women
✍ Mónica Fernández; Jaime Calvo-Alén; Graciela S. Alarcón; Jeffrey M. Roseman; Hol 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

## Abstract ## Objective To determine the differences in clinical manifestations, disease activity, damage accrual, and medication use in systemic lupus erythematosus (SLE) patients as a function of menopausal status at disease onset. ## Methods Women with SLE as per the criteria of the American

Systemic lupus erythematosus in a multie
Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: Association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual
✍ Vilá, Luis M. ;Alarcón, Graciela S. ;McGwin, Gerald ;Bastian, Holly M. ;Fessler, 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## Abstract ## Objective To determine if lymphopenia is associated with clinical/immunologic manifestations, disease activity, and disease damage in systemic lupus erythematosus (SLE). ## Methods The study group comprised 591 patients with SLE participating in a multiethnic, longitudinal outcome

Systemic lupus erythematosus in a multie
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients
✍ Jaime Calvo-Alén; Sergio M. A. Toloza; Mónica Fernández; Holly M. Bastian; Barri 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract ## Objective Venous thrombosis is a relatively frequent and serious complication in systemic lupus erythematosus (SLE) that has been associated with the presence of antiphospholipid antibodies (aPL). However, venous thrombotic events can also be seen in patients without aPL, and only a